Purabi Gen. Insurance Company Ltd. (PURABIGEN)
A
| Insurance
INTRADAY 1MIN CHART
Loading ...
Price: -
Volume: -
Today Analysis
Purabi Gen. Insurance Company Ltd. এর শেয়ারটি 26.20 BDT-এ লেনদেন হচ্ছে, যা বর্তমান ট্রেন্ডে পতনের দিকে। কোম্পানিটির NAV 14.29 BDT-এ অবস্থান করছে, যা দীর্ঘমেয়াদী বিনিয়োগের জন্য একটি নির্দেশক হিসেবে কাজ করে। কোম্পানির P/E Ratio নির্দেশ করে এটি তুলনামূলকভাবে আয়ের চেয়ে কতগুণ বেশি মূল্যে লেনদেন হচ্ছে। টেকনিক্যাল এনালাইসিস অনুযায়ী, সাপোর্ট লেভেল 25.41 BDT-এর কাছাকাছি হতে পারে, যেখানে শেয়ারটি ঘুরে দাঁড়াতে পারে। অন্যদিকে 27.12 BDT-এ একটি সম্ভাব্য রেজিস্ট্যান্স আছে, যেখানে দাম বাধা পেতে পারে। বিনিয়োগের সিদ্ধান্ত নেওয়ার আগে, মার্কেটের সামগ্রিক অবস্থা ও কোম্পানির ফান্ডামেন্টালগুলো বিবেচনা করা জরুরি।
(Disclaimer: This system generated summary is for informational purposes only and does not constitute financial advice.)
Market Depth (Live Order Book)
Buy Orders (Bids)
| Cum Qty | Volume | Price |
|---|---|---|
| No buy orders | ||
Sell Orders (Asks)
| Price | Volume | Cum Qty |
|---|---|---|
| No sell orders | ||
| Date | Close | Volume | Trade | Change | Ch(%) | Open | High | Low |
|---|---|---|---|---|---|---|---|---|
| Loading historical data... | ||||||||
05 Oct, 2026
PURABIGEN: Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2025 to the respective shareholders.
29 Jul, 2026
PURABIGEN: Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.41 for April-June 2026 as against Tk. 0.45 for April-June 2025; EPS was Tk. 0.84 for January-June 2026 as against Tk. 0.78 for January-June 2025. NOCFPS was Tk. 1.01 for January-June 2026 as against Tk. 0.70 for January-June 2025. NAV per share was Tk. 15.50 as on June 30, 2026 and Tk. 14.29 as on December 31, 2025.
26 Jul, 2026
PURABIGEN: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 28, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended June 30, 2026.
23 Jul, 2026
PURABIGEN: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 28, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended June 30, 2026.
19 Jul, 2026
PURABIGEN: Credit Rating Result
Alpha Credit Rating PLC. has assigned Surveillance rating of the Company as "AA+" in the long term and "ST-2" in the short term along with Stable outlook based on audited financial statement up to December 31, 2025 and relevant qualitative information till July 15, 2026.
25 Jun, 2026
PURABIGEN: Resumption after Record Date
Trading of the shares of the company will resume on 28.06.2026.
24 Jun, 2026
PURABIGEN: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 25.06.2026.
22 Jun, 2026
PURABIGEN: Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 23.06.2026 to 24.06.2026 and trading of the shares will remain suspended on record date i.e., 25.06.2026.
02 Jun, 2026
PURABIGEN: Emphasis of Matter
The auditor of the company has given the Emphasis of Matter paragraph in the auditor's report for the year ended December 31, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/218.Purabi%20General25.pdf
13 May, 2026
PURABIGEN: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (13.05.2026) following its corporate declaration.
13 May, 2026
PURABIGEN: Dividend Declaration
The Board of Directors has recommended 10% Cash Dividend for the year ended December 31, 2025. Date of AGM: 30.08.2026, Time: 12:00 PM, Venue/Mode: Digital Platform. Record Date: 25.06.2026. The Company has also reported EPS of Tk. 1.21, NAV per share of Tk. 14.29 and NOCFPS of Tk. 1.39 for the year ended December 31, 2025 as against Tk. 1.54, Tk. 14.09 and Tk. 1.55 respectively for the year ended December 31, 2024.
13 May, 2026
PURABIGEN: Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.43 for January-March 2026 as against Tk. 0.33 for January-March 2025. NOCFPS was Tk. 0.66 for January-March 2026 as against Tk. 0.32 for January-March 2025. NAV per share was Tk. 14.75 as on March 31, 2026 and Tk. 14.29 as on December 31, 2025.
03 May, 2026
PURABIGEN: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 12, 2026 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2025.
03 May, 2026
PURABIGEN: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 12, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended March 31, 2026.
18 Dec, 2025
PURABIGEN: Transmission of Deceased Sponsor's shares to his nominee
The Company has informed that Mr. Md. Khalid Hossain, one of the Sponsor Directors of the company passed away on 07.12.2024. His 1,334,904 shares out of his total holding of 1,374,951 shares of the company will be transmitted to the account of his nominee Ms. Nazneen Akther (wife of Late Md. Khalid Hossain) by way of nomination.
30 Oct, 2025
PURABIGEN: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.45 for July-September 2025 as against Tk. 0.41 for July-September 2024; EPS was Tk. 1.23 for January-September 2025 as against Tk. 1.31 for January-September 2024. NOCFPS was Tk. 0.93 for January-September 2025 as against Tk. 1.08 for January-September 2024. NAV per share was Tk. 14.55 as on September 30, 2025 and Tk. 14.09 as on December 31, 2024.
26 Oct, 2025
PURABIGEN: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 29, 2025 at 4:00 PM to consider, among others, Un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2025.
14 Oct, 2025
PURABIGEN: Prohibition on providing loan facilities to purchase securities
The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase the securities of Purabi Gen. Insurance Company Ltd. in between 1st to 7th trading days following the change of categorization, with effect from today i.e., 14.10.2025 as per BSEC Directive No. BSEC/CMRRCD/2009-193/32 dated December 26, 2021.
14 Oct, 2025
PURABIGEN: Category Change
The Company has been placed in 'A' category from existing 'Z' category with effect from today i.e., 14.10.2025 as the Company has reported disbursement of 10% Cash Dividend for the year ended December 31, 2024.
14 Oct, 2025
PURABIGEN: Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2024 to the respective shareholders.
04 Aug, 2025
PURABIGEN: Credit Rating Result
Alpha Credit Rating PLC. has assigned Surveillance rating of the Company as "AA" in the long term and "ST-2" in the short term along with Stable outlook based on audited financial statement up to December 31, 2024 and relevant qualitative information till August 02, 2025.
31 Jul, 2025
PURABIGEN: Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.45 for April-June 2025 as against Tk. 0.48 for April-June 2024; EPS was Tk. 0.78 for January-June 2025 as against Tk. 0.90 for January-June 2024. NOCFPS was Tk. 0.70 for January-June 2025 as against Tk. 0.54 for January-June 2024. NAV per share was Tk. 14.79 as on June 30, 2025 and Tk. 14.09 as on December 31, 2024.
27 Jul, 2025
PURABIGEN: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 30, 2025 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2025.
29 Jun, 2025
PURABIGEN: Resumption after Record Date
Trading of the shares of the company will resume on 30.06.2025.
26 Jun, 2025
PURABIGEN: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e. 29.06.2025
23 Jun, 2025
PURABIGEN: Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 24.06.2025 to 26.06.2025 and trading of the shares will remain suspended on record date i.e., 29.06.2025.
13 May, 2025
PURABIGEN: Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.33 for January-March 2025 as against Tk. 0.42 for January-March 2024. NOCFPS was Tk. 0.32 for January-March 2025 as against Tk. 0.34 for January-March 2024. NAV per share was Tk. 14.28 as on March 31, 2025 and Tk. 14.09 as on December 31, 2024.
13 May, 2025
PURABIGEN: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (13.05.2025) following its corporate declaration.
13 May, 2025
PURABIGEN: Dividend Declaration
The Board of Directors has recommended 10% cash dividend for the year ended December 31, 2024. Date of AGM: 01.09.2025, Time: 12:00 PM, Venue: MH Samorita Hospital and Medical College, Hall room, 117, Love Road, Tejgaon, Dhaka-1208. Record Date: 29.06.2025. The Company has also reported EPS of Tk. 1.54, NAV per share of Tk. 14.09 and NOCFPS of Tk. 1.55 for the year ended December 31, 2024 as against Tk. 1.19, Tk. 13.77 and Tk. 1.12 respectively for the year ended December 31, 2023.
05 May, 2025
PURABIGEN: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 12, 2025 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2025.
05 May, 2025
PURABIGEN: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 12, 2025 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024.
31 Oct, 2024
PURABIGEN: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.41 for July-September 2024 as against Tk. 0.29 for July-September 2023; EPS was Tk. 1.31 for January-September 2024 as against Tk. 0.76 for January-September 2023. NOCFPS was Tk. 1.08 for January-September 2024 as against Tk. 0.77 for January-September 2023. NAV per share was Tk. 13.91 as on September 30, 2024 and Tk. 13.77 as on December 31, 2023.
27 Oct, 2024
PURABIGEN: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2024 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2024.
16 Oct, 2024
PURABIGEN: Prohibition on providing loan facilities to purchase securities
The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase securities of Purabi General Insurance Company Ltd. with effect from today i.e., October 16, 2024 as per BSEC Directive No. BSEC/CMRRCD/2009-193/32 dated December 26, 2021.
16 Oct, 2024
PURABIGEN: Category Change
The Company has been placed in 'Z' category from existing 'A' category with effect from today i.e., October 16, 2024 as per provision 1(e) of BSEC Directive No. BSEC/CMRRCD/2009-193/77, dated May 20, 2024 regarding non-disbursement of the approved dividend within the stipulated time frame.
04 Aug, 2024
PURABIGEN: Credit Rating Result
Alpha Credit Rating Limited has assigned Surveillance rating of the Company as "AA" in the long term and "ST-2" in the short term along with Stable outlook based on audited financial statement up to December 31, 2023 and relevant qualitative information till July 31, 2024.
31 Jul, 2024
PURABIGEN: Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.48 for April-June 2024 as against Tk. 0.17 (restated) for April-June 2023; EPS was Tk. 0.90 for January-June 2024 as against Tk. 0.46 (restated) for January-June 2023. NOCFPS was Tk. 0.54 for January-June 2024 as against Tk. 0.80 (restated) for January-June 2023. NAV per share was Tk. 14.50 as on June 30, 2024 and 13.77 as on December 31, 2023.
25 Jul, 2024
PURABIGEN: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 30, 2024 at 04:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2024.
Total Records: 12 Years
| Year | Type | Cash(%) | Stock(%) | EPS | NAV | Remarks |
|---|---|---|---|---|---|---|
| 2025 | Final | 10.00% | - | 1.21 | 14.29 | 13-May-2026 |
| 2024 | Final | 10.00% | - | 1.54 | 14.09 | 13-May-2025 |
| 2023 | Final | 10.00% | - | 1.19 | 13.77 | 13-May-2024 |
| 2022 | Final | 7.00% | 3.00% | 1.44 | 13.69 | 30-May-2023 |
| 2021 | Final | 10.00% | - | 1.37 | 13.37 | 15-Jun-2022 |
| 2020 | Final | 5.00% | - | 1.16 | 13.09 | 05-Jul-2021 |
| 2019 | Annual | 10.00% | - | 1.01 | 12.90 | 05-Jul-2020 |
| 2018 | Annual | 12.00% | - | 1.05 | 13.05 | 02-May-2019 |
| 2017 | Annual | - | 12.00% | 1.59 | 13.45 | - |
| 2016 | Annual | - | 10.00% | 1.20 | 13.03 | - |
| 2015 | Annual | - | 12.00% | 1.40 | 13.24 | - |
| 2014 | Annual | - | 15.00% | 1.65 | 13.65 | - |
30-Day Block Transactions
| Date | Max Price | Min Price | Trades | Quantity | Value (Mn) |
|---|---|---|---|---|---|
| No block transactions in the last 30 days. | |||||
Company Info
Trading Code
PURABIGEN
Category : Sector
A : Insurance
NAV
14.29 Tk.
P/E Audited
23.64
Paid up Capital
598.13 crore
Authorized Capital
1,000.00 crore
Market Capital
1,692.69 crore
Total Securities
59,812,506
Reserve & Surplus
72.70 crore
Website
http://www.purabiinsurance.org
Current Shareholding
Public Holding: 2.67 Cr unit
Public: 44.62% (2.67 Cr unit)
Director: 31.58% (1.89 Cr unit)
Institute: 23.78% (1.42 Cr unit)
Foreign: 0.02% (0.00 Cr unit)
Govt: 0.00% (0.00 Cr unit)
EPS History
NAV History
Dividend History
Cash Dividend
Stock Dividend
Historical Monthly Performance
Compare cumulative monthly performance.
Best Month
-
Worst Month
-
Avg MoM
-
Positive
-
Positive Yrs
-
Historical Insight
-
Historical Seasonality
Holding Period Returns
Entry → Exit Analysis
Entry Month:
Select an entry month to view historical holding period outcomes.
* Historical performance is not indicative of future results. Historical calculations are based on past closing prices and do not constitute investment advice. Dividends are not included.
| Period Ending: |
2025
07/10/2026
|
2020
07/10/2026
|
2021
07/10/2026
|
2022
07/10/2026
|
2023
07/10/2026
|
|---|---|---|---|---|---|
| Total Revenues | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Gross Profit | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Operating Expenses | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Operating Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Pre-tax Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Net Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| EBITDA | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| EPS (Basic) | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash & Equivalents | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Current Assets | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Assets | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Current Liabilities | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Liabilities | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Debt | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Equity | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Operations | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Investing | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Financing | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Capital Expenditure | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Free Cash Flow | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Net Change in Cash | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
Unlock Full Financial Data
Upgrade to PRO to access complete historical financial statements, quarterly reports, and deep fundamental analysis.
Upgrade to PROPurabi Gen. Insurance Company Ltd.
A | Insurance
Today-
15 dys-
30 dys-
3 mths-
6 mths-
1 yr-
LTP:-
Open:-
High:-
Low:-
YCP:-
Vol:-
52W H:-
52W L:-
Crct Lw:-
Circuit Up:-
Value:-
M. Cap:-
P/E (Un/A):-
EPS:-
NAV:-
Paid-up:-
Ttl Share:-
Yr end:-
Reserve:-
ROE:-
EPS Q2-
EPS Q3-
EPS ANN-
EPS Q1-
DIV-
DIV YIELD-
Last AGM: -
Record Date: -
Shareholding
(as on -)
Public
0%
Director
0%
Institute
0%
Foreign
0%
Govt.
0%
Market Overview
Loading Data...
(%)
Day Open
Total Trade
Day High
Total Volume
Day Low
Value (Cr)
MARKET STATUS
Up
Down
Unchanged
All Instruments
| Symbol | LTP | Chg% |
|---|---|---|
| Loading... | ||
Sectors
| Sector | Chg% |
|---|---|
| Loading... | |
Stock Screener
Quick Screens
| Symbol | LTP | PE |
|---|---|---|
| Run filter to see results | ||
Alerts
Favorites
Watchlists
Portfolio
My Screeners
| Symbol | LTP | PE |
|---|
Run filter to see results
Market Movers
| # | Symbol | LTP | Chg% |
|---|---|---|---|
| Loading... | |||
AI Insights
Business Pro user exclusive
Login to see